| Active substance |
Temozolomide
|
| Acne |
No
|
| Water Retention |
No
|
| HBR |
No
|
| Hepatotoxicity |
No
|
| Aromatization |
No
|
| Lab Test |
CBC (Complete Blood Count) monitoring
|
| Also known as |
TMZ, Methazolastone
|
| WAREHOUSE |
International Warehouse 2
|
| Blood pressure |
No direct effect
|
| Trade name |
Temodar, Temodal, Temcad
|
| Storage conditions |
Store at controlled room temperature, 20-25В°C (68-77В°F)
|
| Chemical name |
3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide
|
| Formula |
C6H6N6O2
|
| Substance class |
Alkylating agent
|
| Main action |
Antineoplastic
|
| Half-life |
1.8 hours
|
| Dosage (medical) |
Typically 150-200 mg/mВІ per day for 5 days every 28 days cycle
|
| Dosage (sports) |
Not applicable
|
| Effects |
Antitumor effect, crosses the blood-brain barrier
|
| Side effects |
Nausea, vomiting, constipation, loss of appetite, alopecia, headache, fatigue, neutropenia, thrombocytopenia
|
| Use in sports |
None
|
| Manufacturer |
MSD
|
|
There are no reviews yet.